Abbott LaboratoriesMEX:ABT +1.26%81 PB Ratio is 2.98 as of Jun. 25, 2026, which is 37% below its 10-year median of 4.70. GuruFocus rates MEX:ABT with a GF Score™ of 81/100 and a GF Value™ of MXN2,296.73 (Significantly Undervalued). Among 788 Medical Devices & Instruments companies, Abbott Laboratories ranks worse than 64.47% on this metric.
Abbott Laboratories stock PB Ratio (=3.03) is close to 5-year low of 2.82.
The historical rank and industry rank for Abbott Laboratories's PB Ratio or its related term are showing as below:
MEX:ABT'
s PB Ratio Range Over the Past 10 Years
Min: 2.36 Med: 4.7 Max: 7.15
Current: 3.03
During the past 13 years, Abbott Laboratories's highest PB Ratio was 7.15. The lowest was 2.36. And the median was 4.70.
MEX:ABT's PB Ratio is ranked worse than 64.47% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs MEX:ABT: 3.03
During the past 12 months, Abbott Laboratories's average Book Value Per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 12.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 7.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Abbott Laboratories was 19.20% per year. The lowest was -5.30% per year. And the median was 10.20% per year.
Back to Basics: PB Ratio
Abbott Laboratories (MEX:ABT) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Abbott Laboratories PB Ratio Related Terms
Abbott Laboratories PB Ratio Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's PB Ratio distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Abbott Laboratories (MEX:ABT) has a PB Ratio of 2.98 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Abbott Laboratories and its competitors. This is 37% below median its historical median of 4.70. Over the past decade, Abbott Laboratories' PB Ratio has ranged from 2.36 to 7.15. According to the industry distribution chart, Abbott Laboratories ranks #508 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 64.5%.
Is Abbott Laboratories' PB Ratio too high?
Abbott Laboratories' current PB Ratio of 2.98 is 37% below median its 10-year median of 4.70. Over the past 10 years, this metric has ranged from a low of 2.36 to a high of 7.15. The Medical Devices & Instruments industry median PB Ratio is 2.05. Abbott Laboratories' value of 2.98 is 45.7% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #508 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' PB Ratio compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #508 out of 788 companies for PB Ratio. This places Abbott Laboratories in the lower half of its industry. The industry median PB Ratio is 2.05. Abbott Laboratories' value of 2.98 is 45.7% above this benchmark. Historically, Abbott Laboratories' own PB Ratio has ranged from 2.36 to 7.15 over the past decade. While the company's 10-year median is 4.70 vs. the industry median of 2.05, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current PB Ratio of 2.98 is 45.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current PB Ratio is 2.98, which is 37% below median its own 10-year median of 4.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (MEX:ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN2,296.73, compared to a current price of MXN1,605.00 — trading 30.1% below its estimated fair value. The current PB Ratio is 2.98, which is 37% below median its 10-year median of 4.70 and 45.7% above the Medical Devices & Instruments industry median of 2.05. Abbott Laboratories' overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Abbott Laboratories (MEX:ABT), the current PB Ratio is 2.98 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (MEX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of MXN1,605.00 is trading 30.1% below its estimated GF Value™ of MXN2,296.73.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for MEX:ABT:
PB Ratio: 2.98 (37% below median its 10-year median of 4.70)
GF Value™: MXN2,296.73 vs. price of MXN1,605.00 (30.1% below fair value)
Industry Position: 45.7% above the Medical Devices & Instruments median (#508 of 788)
No single metric tells the full story. See the MEX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
81GF Score
Get the complete analysis for MEX:ABT
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ABT has been successfully added to your 
